Employment Status of Patients with ESRD and the Subsequent treatment modalities in the United State

John D Sullivan*

Received: March 06, 2019;   Published: March 11, 2019

DOI: 10.32474/JUNS.2019.01.000119

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Introduction

End Stage Renal Disease impacts the lives of over 725,000 Americans and their families. In 1972, despite the cost of supporting a rapidly growing chronic condition at the time, the United States initiated a system whereby everyone would be treated that qualifies for social security benefits, after a waiting period of three years (Medicare Secondary Payer was slowly extended over the years to 36 months after diagnosis as it currently stands), regardless of age, providing the platform for the debate of a potential nationalized health care system that currently seems to be in a period of uncertainty. However, over three decades through significant consolidation, the treatment of dialysis via two large provider chains (one fully integrated) have directed patients to hemodialysis in the out-patient setting without considering the technological or clinical benefits of home hemodialysis or peritoneal dialysis [1,2].

Introduction| Overview| The Economics of Dialysis| Profitability| Conclusion| References|